Tag: Faricimab
Faricimab, an eye medicine from Roche, should be approved with a local phase III trial waiver, according to the SEC.
Faricimab intravitreal injection, manufactured by Swiss multinational pharmaceutical company Roche, has been approved for import and marketing in…
Registration Form
This will close in 0 seconds
